Benzinga  Dec 11  Comment 
Vical Incorporated (Nasdaq: VICL) today announced the completion of enrollment in a Phase 1/2 trial of its Vaxfectin^®-formulated therapeutic vaccine for herpes simplex virus type 2 (HSV-2), the predominant cause of recurrent genital herpes....
StreetInsider.com  Oct 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Vical%2C+Inc.+%28VICL%29+Receives+Six+HSV-2-Related+U.S.+Patents/9894973.html for the full story.
SeekingAlpha  May 1  Comment 
Vical, Inc. (VICL) Q1 2014 Results Earnings Conference Call May 01, 2014 12:00 PM ET Executives Tony Ramos - Chief Accounting Officer Vijay Samant - President and CEO Dr. Larry Smith - VP Vaccine Research Analysts ...
SeekingAlpha  Feb 13  Comment 
Vical, Inc (VICL) Q4 2013 Earnings Conference Call February 12, 2014 12:00 AM ET Executives Tony Ramos - Chief Accounting Officer Vijay Samant - President and CEO Analyst Jonathan Eckard - Citigroup Presentation ...
StreetInsider.com  Feb 12  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Vical%2C+Inc.+%28VICL%29+Tops+Q4+EPS+by+6c/9156260.html for the full story.
SeekingAlpha  Jan 15  Comment 
By Theodore Cohen: What's up with Vical's (VICL) stock? There's no question the market has been treating it like the red-headed stepchild since the company's former lead product, Allovectin 7, failed its Phase 3 trial late last summer. But...
DailyFinance  Dec 24  Comment 
NEW YORK, NY -- (Marketwired) -- 12/24/13 -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of California on behalf of investors who purchased Vical...

You may also be interested in articles related to Vical (VICL):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki